| Paramount Nursing And Rehab At Fayetteville, Llc | |
| 6375 Chambersburg Road, Fayetteville, Pennsylvania 17222 | |
| (717) 352-2721 | |
| Name | Paramount Nursing And Rehab At Fayetteville, Llc |
|---|---|
| Location | 6375 Chambersburg Road, Fayetteville, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 92 |
| Occupancy Rate | 69.24% |
| Medicare ID (CCN) | 395721 |
| Legal Business Name | Paramount Nursing And Rehabilitation At Fayetteville Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1033558473 |
| Address | 6375 Chambersburg Rd, Fayetteville, PA 17222 |
| Phone Number | 717-352-2721 |
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
| NPI Number | 1285121939 |
| Organization Name | PARAMOUNT HEALTH HOLDINGS GROUP, INC. |
| Doing Business As | PARAMOUNT NURSING AND REHABILITATION AT FAYETTEVILLE, LLC |
| Address | 6375 Chambersburg Rd, Fayetteville, PA 17222 |
| Phone Number | 717-352-2721 |
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
| NPI Number | 1487760765 |
| Organization Name | PINEY PARTNERS LP |
| Doing Business As | THE VILLAGE OF LAUREL RUN |
| Address | 6375 Chambersburg Rd, Fayetteville, PA 17222 |
| Phone Number | 717-352-2721 |
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
| NPI Number | 1548608557 |
| Address | 6375 Chambersburg Rd, Fayetteville, PA 17222 |
| Phone Number | 717-352-2721 |
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
| NPI Number | 1740628858 |
| Address | 6375 Chambersburg Rd, Fayetteville, PA 17222 |
| Phone Number | 717-352-2721 |
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
| NPI Number | 1760841167 |
| Organization Name | PASSAGE VILLAGE OF LAUREL RUN OPERATIONS, LLC |
| Doing Business As | LAUREL CARE NURSING & REHABILITATION CENTER |
| Address | 6375 Chambersburg Rd, Fayetteville, PA 17222 |
| Phone Number | 717-352-2721 |
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
| NPI Number | 1881192524 |
| Organization Name | PARAMOUNT NURSING AND REHABILITATION AT FAYETTEVILLE, LLC |
| Address | 6375 Chambersburg Rd, Fayetteville, PA 17222 |
| Phone Number | 717-352-2721 |
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
| NPI Number | 1942649389 |
| Address | 6375 Chambersburg Rd, Fayetteville, PA 17222 |
| Phone Number | 717-352-2721 |
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.91 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.22 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 70.27 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.9 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 9.38 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.35 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.94 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 20.58 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 71.87 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.1 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 25.04 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.72 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.33 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.67 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 72.17 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 81.77 | 82.93 |
News Archive
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
In a recent study, researchers developed a methodology to detect SARS-CoV-2 RNA in wastewater with the potential for finding an association between the wastewater treatment plant (WWTP) SARS-CoV-2 influent viral RNA load and COVID-19 cases in the community. This study indicates that a national scale wastewater-based epidemiology can play a role in COVID-19 surveillance.
SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
Recent outbreaks of plague, tularemia and increasing incidents of rabies exposure highlight the importance of zoonotic disease education for physicians and public health professionals.
Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.
› Verified 6 days ago
Paramount Nursing And Rehab At Fayetteville, Llc Location: 6375 Chambersburg Road, Fayetteville, Pennsylvania 17222 Phone: (717) 352-2721 |